Tanshinone IIA Alleviates Mitochondrial Dysfunction in Lipopolysaccharide-Induced Acute Kidney Injury in Mice by Activating SIRT1/PINK1-Mediated Mitophagy
Iranian Journal of Pharmaceutical Research · 24.05.2026 · 25 (1)
DOI: 10.5812/ijpr-169885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 24.05.2026. Verfasst von Xiaoli Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Affiliated Hospital of Northwest University, Xi'an No.3 Hospital, Xi'an, China. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acute kidney injury (AKI) is a critical clinical condition closely associated with mitochondrial dysfunction. Tanshinone IIA has been shown to exert protective effects against AKI; however, the underlying mechanisms remain unclear.
Objectives
This study aimed to investigate whether Tanshinone IIA mitigates lipopolysaccharide (LPS)-induced AKI through SIRT1/PINK1-mediated mitophagy.
Methods
A mouse model of AKI was established by intraperitoneal injection of LPS. Renal function was assessed by measuring serum creatinine (Scr) and blood urea nitrogen (BUN) levels. Renal histopathological changes were evaluated using hematoxylin and eosin (HE) staining. Mitochondrial function was assessed by measuring adenosine triphosphate (ATP) content, mitochondrial reactive oxygen species (ROS), and mitochondrial membrane potential in renal tissue. The expression of mitophagy-related markers was analyzed by Western blotting.
Results
Lipopolysaccharide treatment significantly increased Scr and BUN levels and induced marked renal pathological injury in mice compared with those in the control group. Tanshinone IIA intervention reduced Scr and BUN levels and alleviated renal tissue damage. Mitochondrial function analysis showed that Tanshinone IIA restored the LPS-induced reduction in ATP content, suppressed excessive mitochondrial ROS generation, and stabilized the mitochondrial membrane potential. Mechanistic analyses further demonstrated that Tanshinone IIA upregulated the LPS-induced expression of SIRT1 and PINK1, increased the LC3-II/LC3-I ratio, and promoted p62 degradation.
Conclusions
Tanshinone IIA protects against LPS-induced AKI by improving mitochondrial function through the activation of SIRT1/PINK1-mediated mitophagy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, The Affiliated Hospital of Northwest University, Xi'an No.3 Hospital, Xi'an, China.
- Department of Biology, Faculty of Science, Al-Baha University, Al Baha, Saudi Arabia.
- Department of Zoology, Faculty of Science, Helwan University, Helwan, Egypt.
- Department of Urinary Surgery, Ankang People's Hospital, Ankang, China.
Zitieren
APA
Guo, X., Gao, Y., Kassab, R. B., & Zhang, F. (2026). Tanshinone IIA Alleviates Mitochondrial Dysfunction in Lipopolysaccharide-Induced Acute Kidney Injury in Mice by Activating SIRT1/PINK1-Mediated Mitophagy. Iranian Journal of Pharmaceutical Research, 25(1). https://doi.org/10.5812/ijpr-169885
Vancouver
Guo X, Gao Y, Kassab RB, Zhang F. Tanshinone IIA Alleviates Mitochondrial Dysfunction in Lipopolysaccharide-Induced Acute Kidney Injury in Mice by Activating SIRT1/PINK1-Mediated Mitophagy. Iranian Journal of Pharmaceutical Research. 2026;25(1). doi:10.5812/ijpr-169885
BibTeX
@article{Guo2026,
author = {Guo, Xiaoli and Gao, Yi and Kassab, Rami B and Zhang, Fangdi},
title = {Tanshinone IIA Alleviates Mitochondrial Dysfunction in Lipopolysaccharide-Induced Acute Kidney Injury in Mice by Activating SIRT1/PINK1-Mediated Mitophagy},
journal = {Iranian Journal of Pharmaceutical Research},
year = {2026},
volume = {25},
number = {1},
doi = {10.5812/ijpr-169885}
}
EUVIMED